Clinical Trial Update: Role of Nebulized Dexmedetomidine in Blunting the Effects of Direct Laryngoscopy and Endotracheal Tube on Heart Rate and Blood Pressure. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating nebulized dexmedetomidine to blunt hemodynamic responses (heart rate and blood pressure changes) during direct laryngosco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemodynamic Instability

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Muhammad Haroon Anwar | Conditions: Hemodynamic Instability | Phase 4 | Status: UNKNOWN